English
TOPページ
学術雑誌
学会発表
学歴
(最終更新日:2022-08-03 13:14:15)
サカイ アキコ
坂井 晶子
所属
医学部 医学科(東京女子医科大学病院) 循環器内科
職種
助教
■
学術雑誌
1.
原著
機能的心筋虚血検出のためのCT-iFRの開発 心筋SPECT/PETとの対比 2020/11
2.
原著
Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI. 2020/03
3.
原著
ステロイド治療後の病態評価に心臓MRIが有用であった両室ペーシング機能付き植込み型除細動器(CRT-D)植込み後の心臓サルコイドーシスの1例 2020/02
4.
総説
【心臓サルコイドーシスの画像診断-病態・臨床からみた考え方-】 心臓サルコイドーシスのMRI 存在診断から、病態・治療・予後評価へ 2017/07
5.
原著
Gender differences in predictors of left ventricular myocardial relaxation in non-obese, healthy individuals. 2015/04
6.
その他
心アミロイドーシスにおける新蔵MRI画像所見 2010
7.
原著
Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide 2009
8.
症例報告
心不全の原因としてタコつぼ心筋症か心内膜下梗塞か診断に苦慮した一例 2009
9.
原著
Delayed enhancement on computed tomography in abdominal aortic aneurysm wall. 2007
10.
原著
Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. 2004
11.
原著
A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. 2002
12.
原著
An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. 2002
13.
原著
Expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells is upregulated in cystic medial degeneration of annuloaortic ectasia in Marfan syndrome. 2002
14.
原著
血管壁における大動脈解離発症後のMatrix metallo proteinase-2の発現と経時変化 2002
5件表示
全件表示(14件)
■
学会発表
1.
Lipoprotein(a) Levels is Associated with Abdominal Aortic Aneurysm in Patients with Dyslipidemia 2022/03/12
2.
冠微小循環の最適診断法(13N-ammonia PET for Diagnosis and Monitoring of Microvascular Angina) (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2022/03/11
3.
脂質異常症の入院患者におけるリポタンパク質(a)濃度とアテローム動脈硬化腹部大動脈瘤の関連性(Association of lipoprotein(a) levels and atherosclerotic abdominal aortic aneurysm inpatients with dyslipidemia) (口頭発表,一般) 2021/10/24
4.
Aortic Valve Calcification and Prognostic Evaluation in Patients with Heterozygous Familial Hypercholesterolemia (口頭発表,一般) 2021/03
5.
Lipoprotein(a) is a Risk Factor for the Primary Cardiovascular Event in Patients with Heterozygous Familial Hypercholesterolemia (口頭発表,一般) 2021/03
6.
Lipoprotein(a) is residual risk factor for the atherosclerotic cardiovascular disease in patients with LDL-C hypercholesterolemia (口頭発表,一般) 2021/03
7.
PCSK9 Gene Mutations Have a Higher Risk of Cardiovascular Events than LDL Receptor Abnoramalities in Heterozygous Familial Hypercholesterolemia (口頭発表) 2021/03
8.
Proprotein Convertase Subtilisin/Kexin Type 9(PCSK-9) Inhibitors Improve Cholesterol Level and Indicator of Atherosclerosis in High-risk Familial Hypercholesterolemia (口頭発表,一般) 2021/03
9.
高脂血症患者においてリポタンパク質(a)濃度は腹部大動脈瘤と関連している(Lipoprotein(a) levels is associated with abdominal aortic aneurysm in dyslipidemia patients) (口頭発表) 2020/07/17
10.
Aortic Valve Calcification Predicts Subclinical Coronary Atherosclerosis in Heterozygous Familial Hypercholesterolemia Patients with High LP (a) Levels (口頭発表,一般) 2020/07
11.
Cardiovascular Dysfunction in Heterozygous Familial Hypercholesterolemia Patients with Diabetes Mellitus (口頭発表,一般) 2020/07
12.
High Apolipoprotein-B Level is a Risk Factor of Secondary Cardiovascular Incidence in Patients with Familial Hypercholesterolemia (口頭発表,一般) 2020/07
13.
Young Female Japanese Patients with High-risk Familial Hypercholesterolemia were at High Risk of Cardiovascular Events (ポスター,一般) 2020/07
14.
糖尿病のヘテロ接合型家族性高コレステロール血症患者における心血管機能障害(Cardiovascular dysfunction in heterozygous familial hypercholesterolemia patients with diabetes mellitus) (口頭発表,一般) 2020/07
15.
日本人高リスク家族性高コレステロール血症患者において女性患者は心血管有害事象がリスクが高かった(The patients with female were high risk at cardiovascular events in Japanese High-risk Familial Hypercholesterolemia) (口頭発表) 2020/07
16.
Activation of Effector Memory and Effector T Cells in Patients with Familial Hypercholesterolemia. (ポスター,一般) 2019/12/11
17.
Aortic Valve Calcification and Subclinical Coronary Atherosclerosis in Japanese Heterozygous Familial Hypercholesterolemia Patients With High Lp(a) Levels (ポスター,一般) 2019/11/17
18.
家族性高コレステロール血症における,心血管病変既往の有無と大動脈弁石灰化,脂質プロファイルとの関連性 (ポスター,一般) 2019/09/14
19.
Papillary muscle ischemia and global myocardial flow reserve: assessment by highresolution cine imaging of 13N ammonia PET (ポスター,一般) 2019/09/02
20.
GLP-1受動体作動薬が糖尿病および肝機能障害に有効であった筋強直ジストロフィーの同胞例 (ポスター,一般) 2019/08/02
21.
Apolipoprotein-B(Apo-B)は高コレステロール血症患者の心血管二次予防において強いリスク因子となる (ポスター,一般) 2019/07/12
22.
Simultaneous analysis of heart and kidney oxygenation using T2 BOLD MRI: investigation of cardiorenal relationship. (ポスター,一般) 2019/05/13
23.
Aortic Valve Calcification and Subclinical Coronary Atherosclerosis in Japanese Heterozygous Familial Hypercholesterolemia Patients with Gene Mutation (ポスター,一般) 2019/03/31
24.
Progression of Fibrosis in Hypoxic Area of Hypertrophic Cardiomyopathy: Demonstration by Cardiac T2* BOLD and T1 Mapping MRI (口頭発表,一般) 2019/03/31
25.
Relation between Effector Memory T Cells with Activation of Kv1.3 and Severity of Heart Failure (口頭発表,一般) 2019/03/31
26.
Cardiac Magnetic Resonance T1 Mapping and Late Gadolinium Enhancement Surrogate Major Cardiac Events in Systemic Sclerosis (ポスター,一般) 2019/03/30
27.
Detection of Myocardial Inflammation in Sarcoidosis Using Cardiac Magnetic Resonance T2 Mapping (口頭発表,一般) 2019/03/30
28.
Familial Hypercholesterolemia is High Risk of Cardiovascular Event Regardless of Age and Sex (ポスター,一般) 2019/03/30
29.
Papillary Muscle Ischemia and Global Myocardial Flow Reserve in Coronary Artery Disease: Assessment by High-resolution Cine Imaging of 13Nammonia PET (口頭発表,一般) 2019/03/30
30.
TWMU Cardiovascular Imaging Team Collaborating with Cardiologists and Radiologists: Current Situation and Problem (口頭発表) 2019/03/30
31.
Genetic Diagnosis of Familial Hypercholesterolemia and the Risk of Cardiovascular Events (口頭発表,一般) 2019/03/29
32.
Prediction of Cardiac Resynchronization Therapy Response in Dilated Cardiomyopathy Using Vortex Flow Mapping on Cine Magnetic Resonance Imaging (ポスター,一般) 2019/03/17
33.
Cardiac sarcoidosis with features mimicking arrhythmogenic right ventricular cardiomyopathy (口頭発表,一般) 2019/02/09
34.
心臓 MRI が診断と病態評価に有用であった SLE に合併した心膜心筋炎の 1 例 (ポスター,一般) 2019/01/25
35.
年齢性差によらない心血管イベントハイリスク:家族性高コレステロール血症 (口頭発表,一般) 2019/01/20
36.
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitor Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in Japanese High-Risk Familia Hypercholesterolemia (ポスター,一般) 2018/11/12
37.
Aortic Vale calcification and coronary atherosclerosis in familial hypercholesterolemia patients (口頭発表,一般) 2018/09/22
38.
家族性高コレステロール血症患者における動脈硬化進展の性差について (ポスター,一般) 2018/09/08
39.
Underdiagnosis and non-treatment of heterozygous familial hypercholesterolemia in association with cardiovascular disease (ポスター,一般) 2018/08/28
40.
Analysis of myocardial fibrosis using cardiac magnetic resonance T1 imaging and late gadolinium enhancement: Association with ventricular tachycardia in hypertrophic cardiomyopathy (ポスター,一般) 2018/08/27
41.
心血管病変既往の有無による家族性高コレステロール血症と大動脈弁石灰化、脂質プロファイルとの関連性 (ポスター,一般) 2018/07/12
42.
心血管病変既往による家族性高コレステロール血症と原発性脂質異常症患者の脂質プロファイル、血管内皮機能および冠動脈プラークの違い (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2018/07/03
43.
Myocardial oxygenation using T2 BOLD cardiac MRI with compressed SENSE: Association with myocardial fibrosis and contraction in hypertrophic cardiomyopathy. (ポスター,一般) 2018/06/20
44.
Proprotein Convertase Subtilisin/kexin Type 9 (PCSK-9) inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque in Familial Hypercholesterolemia (ポスター,一般) 2018/06/09
45.
Analysis of Myocardial Fibrosis Using Cardiac
Magnetic Resonance T1 Imaging and Late
Gadolinium Enhancement: Association with Ventricular
Tachycardia in Hypertrophic Cardiomyopathy (ポスター) 2018/03/25
46.
Analysis of Myocardial Fibrosis Using Cardiac Magnetic Resonance T1 Imaging and Late Gadolinium Enhancement: Association with Ventricular Tachycardia in Hypertrophic Cardiomyopathy (ポスター,一般) 2018/03/25
47.
Aortic Valve Calcification and Subclinical Coronary Atherosclerosis Using Computed Tomography in Japanese Heterozygous Familial Hypercholesterolemia Patients with Gene Mutation (ポスター,一般) 2018/03/25
48.
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in High-risk Familial Hypercholesterolemia. (ポスター,一般) 2018/03/25
49.
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in High-risk Familial Hypercholesterolemia. (ポスター,一般) 2018/03/25
50.
The Impact of 18F-fluorodeoxyglucose Uptake on Serial Cardiac Positron Emission Tomography Guided Therapy in Patients with Cardiac Sarcoidosis (口頭発表,一般) 2018/03/25
51.
Heterozygous Familial Hypercholesterolemia: Insight into Polygenetic Abnormalities in Japanese Patients (口頭発表,一般) 2018/03/24
52.
Quantitative Analysis of 18F-fluorodeoxyglucose Positron Emission Tomography Re-uptake in the Evaluation of Relapse of Cardiac Sarcoidosis (ポスター,一般) 2018/03/24
53.
Sufficient Reduction in FDG Uptake on Serial Cardiac-PET is Associated with Improvement of Cardiac Function in Patients with Cardiac Sarcoidosis (ポスター,一般) 2018/03/24
54.
Assessment of Cardiovascular Atherosclerosis of Heterozygous Familial Hypercholesterolemia (hFH) Using 320-detector Row Coronary CT (ポスター,一般) 2018/03/23
55.
Detection of Myocardial Fibrosis in Cardiomyopathy Using High-temporal Tagging-MRI: Comparison with Feature-tracking MRI (口頭発表,一般) 2018/03/23
56.
The Strict Management of Low-Density Lipoprotein Cholesterol in Heterozygous Familial Hypercholesterolemia for the Secondary Prevention of Cardiovascular Disease (ポスター,一般) 2018/03/23
57.
Underdiagnosis and Non-treatment of Heterozygous Familial Hypercholesterolemia in Association with Cardiovascular Disease (口頭発表,一般) 2018/03/23
58.
Is Disease Activity of Cardiac Sarcoidosis Suppressed During Maintenance Dose Period of Corticosteroid Therapy? Evaluation by FDG-PET (ポスター,一般) 2018/03/12
59.
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9)Inhibitors Improve Lipid Profile and Vascular Atherosclerotic
Plaque Formation in High-Risk Familial Hypercholesterolemia (ポスター,一般) 2018/03/11
60.
Polygenetic Abnormalities in Japanese Patients With Heterozygous Familial Hypercholesterolemia (ポスター,一般) 2018/03/10
61.
シネ MRI の Vortex Flow Map による拡張型心筋症の心臓再同期療法の効果予測 (口頭発表) 2018/01/12
62.
Insight into Polygenetic Abnormalities in Japanese Heterozygous Familial Hypercholesterolemia (ポスター,一般) 2018/01/06
63.
Underdiagnosis and Undertreatment of Heterozygous Familial Hypercholesterolemia in Association With Cardiovascular Disease (ポスター,一般) 2017/11/14
64.
Aortic valve calcification and coronary plaque morphology in Japanese heterozygous familial hypercholestestreolemia patients with gene mutation (ポスター,一般) 2017/11/11
65.
LDL-C管理目標値の再考が必要であった家族性高コレステロール血症の1例 (ポスター,一般) 2017/09/30
66.
ハイリスク家族性高コレステロール血症患者におけるPSCK-9阻害剤の短期的脂質改善効果と中期的な血管プラーク消退効果 (口頭発表,一般) 2017/09/30
67.
Gender Difference of Atherosclerotic Development in Heterozygous Familial Hypercholesterelemia (ポスター,一般) 2017/09/16
68.
Under-diagnosis and Under-treatment of Heterozygous Familial Hypercholesterelaemia in Patients with Cardiovascular Diseases (ポスター,一般) 2017/08/29
69.
Polygenetic Abnormalities in Japanese Patients with Heterozygous Familial Hypercholesterolemia (ポスター,一般) 2017/07/07
70.
Assessment of cardiovascular atherosclerosis of heterozygous familial hypercholesterolemia (hFH) using 320-slice coronary CT (口頭発表,一般) 2017/07/06
71.
Assessment of cardiovascular atherosclerosis of heterozygous familial hypercholesterolemia(hFH)using 320-slice coronary CT (ポスター,一般) 2017/07/06
72.
Myocardial fibrosis on cardiac magnetic resonance T1 imaging associates with adverse cardiac event in non-ischemic cardiomyopathy (口頭発表,一般) 2017/06/02
73.
Underdiagnosis and Under Treatment of Heterozygous Familial Hypercholesterelemia in Cardiovascular Diseases (ポスター,一般) 2017/03/19
74.
Geometric Dysfunction and Myocardial Fibrosis in Cardiomyopathy: Demonstration by 3T High-temporal Tagged CMR (ポスター,一般) 2017/03/18
75.
The prevalence of polygenetic abnormality in heterozygous familial hypercholesterolemia (ポスター,一般) 2017/03/18
76.
320列 CT 冠動脈フローイメージによる心筋虚血検出:アンモニア PET との比較 (口頭発表,一般) 2017/01/21
77.
治療の効果と経過を multimodality で観察しえた、急性心筋炎を合併した好酸球性多発血管炎性肉芽腫症の一例 (口頭発表,一般) 2017/01/20
78.
Assessment of cardiovascular atherosclerosis of Familial Hypercholesterolaemia (hFH) using 320-slice coronary CT (口頭発表,一般) 2016/12/08
79.
家族性高コレステロール血症患者(FH)における冠動脈CTによる冠動脈プラーク病変評価 (ポスター,一般) 2016/09/23
80.
Diagnostic value of transluminal attenuation gradient in coronary computed tomographic imaging for the evaluation of functionally coronary stenosis (ポスター,一般) 2016/08/30
81.
Heterozygous Familial Hypercholesterelemia with Cardiovascular Diseases (ポスター,一般) 2016/07/15
82.
左室流出路圧較差軽減に難渋した左室肥大を伴わない収縮期僧帽弁前方運動の一症例 (ポスター,一般) 2015/09/18
83.
Waist Circumference Predicts Abnormal Left Ventricular Relaxation in Men: Data Obtained through Thorough Physical Examinations in Healthy Subjects (ポスター,一般) 2013/03/09
84.
TI-BMIPP SPECTの非特異的なスポット状の血流代謝剥離像から示唆されたcardiac syndrome Xの一例 (口頭発表,一般) 2013/02/09
85.
ニコチン依存症を合併する睡眠時無呼吸症候群患者の睡眠状態と抑うつ傾向 (ポスター,一般) 2012/06
86.
ニコチン依存症を合併する睡眠時無呼吸症候群患者の睡眠状態と抗うつ傾向 (口頭発表,一般) 2012/04/04
87.
Aortic stiffness estimated by cardiovascular magnetic resonance correlates with clinical events in patients with hypertrophic cardiomyopathy. (口頭発表,一般) 2011/08/28
88.
Aortic Stiffness Estimated by MRI is Increased in Patients with Systemic Sclerosis in the Abisence of Apparent Cardiovascular Involvement (口頭発表,一般) 2011/08
89.
What are the High Risk Factors for Coronary Atherosclerosis,Adipocytekines,Epicardilal Fat,Visceral Fat,or the Other Metabolic Factors? (口頭発表,一般) 2011/08
90.
1071-Evaluation of plaque Morphology and Epicardial Fat by 64-Slice Multi-Detector Computed Tomography(MDCT)Associated With Glucose Levels. (口頭発表,一般) 2010/11
91.
心アミロイドーシスにおける心臓MRI所見と剖検心臓大切片標本との比較 (口頭発表,一般) 2010/07
92.
心アミロイドーシスにおける新蔵MRI画像所見 (一般) 2010/06
93.
Evaluation of Plaque Morphology and Pericardial Fat by 64-slice Multi-detector Computed Tomography(MDCT) Associated with Glucose Levels (口頭発表,一般) 2010/03
94.
心サルコイドーシスにおける遅延造影MRI像とTl-201画像との比較 (口頭発表,一般) 2009/10
95.
EVAHEART植え込み後にcornary CTAを施行したDCMの一例 (一般) 2008/07
96.
左室に進展を伴ったARVCの1症例 (一般) 2008/07
97.
心サルコイドーシスの遅延造影像 特徴的なMRI所見 (一般) 2008/07
98.
拡張相肥大型心筋症におけるMRI像:肥大型心筋症との比較 (口頭発表,一般) 2005/11/26
99.
The optimum timing of Bentall’s operation for the patients with Marfan syndrome who have annulo aortic ectasia: Discussion based on our experiences. (ポスター,一般) 2000/11
100.
Marfan症候群患者のBentall手術施行後長期フォローアップ中における心血管合併症再発の危険因子:第2の手術の予測は可能か? (ポスター,一般) 2000/03
5件表示
全件表示(100件)
■
学歴
1.
東京女子医科大学 医学部 卒業 学士(医学)
2.
東京女子医科大学 医学部 博士課程修了 博士(医学)